For a 60‑year‑old female weighing 53 kg with chronic kidney disease (creatinine 2.07 mg/dL, eGFR ≈ 27 mL/min) on prednisone 5 mg daily and currently using insulin glargine (Lantus) 18 U at 8 am with rapid‑acting insulin (ICR 11 U per 50 g carbohydrate), what should her insulin‑to‑carbohydrate ratio (ICR), insulin sensitivity factor (ISF), and basal insulin (Lantus) dose be?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Insulin Dose Adjustments for Recurrent Hypoglycemia

This patient is experiencing severe, recurrent hypoglycemia requiring urgent reduction of all insulin doses—reduce Lantus to 12 units (33% reduction), eliminate correction insulin temporarily, and adjust ICR to 1:15 (from 1:11) to prevent life-threatening hypoglycemia in the setting of advanced CKD, poor oral intake, and prednisone use.

Critical Context: High-Risk Patient Profile

This 60-year-old woman has multiple high-risk features for severe hypoglycemia 1:

  • Advanced CKD (eGFR 27 mL/min, Stage 4): Dramatically impairs insulin clearance
  • Low body weight (53 kg): Increases insulin sensitivity per unit dose
  • Poor oral intake: Unpredictable carbohydrate absorption
  • Age >65 years: Increased hypoglycemia risk
  • Recent severe hypoglycemia: BG 48 at 1800, BG 60 at 0200 requiring D50

The pattern shows clear insulin excess: correction dose at noon (2 units for BG 144) led to hypoglycemia 6 hours later, and overnight hypoglycemia occurred despite adequate evening glucose.

Basal Insulin (Lantus) Adjustment

Recommended Dose: 12 units daily (down from 18 units)

Rationale:

  • Current dose represents 0.34 units/kg—already at the lower end of typical dosing
  • In CKD Stage 4, insulin requirements for long-acting analogues like glargine decrease by approximately 30% compared to normal renal function 2
  • Guidelines recommend 25-30% reduction in basal insulin for patients with CKD Stage 3-4 3
  • For hypoglycemia without clear cause, reduce dose by 10-20% initially 4, 5, but this patient needs more aggressive reduction given recurrent severe episodes
  • Research shows insulin glargine requirements decline significantly at eGFR <60 mL/min 2, 6

Monitoring: Check fasting glucose daily. If fasting BG consistently >180 mg/dL for 3 days, increase by 2 units 4.

Insulin Sensitivity Factor (ISF)

Recommended ISF: 1:80 (one unit lowers BG by 80 mg/dL)

Current ISF appears to be approximately 1:50 based on the correction:

  • 2 units given for BG 144 (likely targeting ~100)
  • This suggests 1 unit expected to lower BG by ~22-25 mg/dL
  • This is far too aggressive for this patient

Calculation for safer ISF:

  • Use "1800 rule" adjusted for CKD: 1800 ÷ estimated total daily dose
  • Estimated TDD after reduction: ~25 units (12 basal + ~13 prandial)
  • 1800 ÷ 25 = 72, round to 80 for safety margin

Critical caveat: With poor oral intake and recurrent hypoglycemia, hold all correction insulin for 5-7 days until glycemic pattern stabilizes 4, 7. Resume only when pre-meal BG consistently >200 mg/dL.

Insulin-to-Carbohydrate Ratio (ICR)

Recommended ICR: 1:15 (one unit per 15 grams carbohydrate)

Current ICR analysis:

  • Patient ate 65g CHO at 10 am
  • Current ICR 1:11 would suggest ~6 units needed
  • She received 2 units correction (for BG 144), suggesting minimal prandial insulin was given
  • However, hypoglycemia occurred 6 hours later (BG 48 at 1800)

Safer ICR calculation:

  • Use "500 rule" adjusted for CKD: 500 ÷ TDD
  • 500 ÷ 25 = 20
  • However, given prednisone 5 mg daily (causes insulin resistance), compromise at 1:15
  • This is more conservative than 1:11, reducing prandial insulin by ~27%

Implementation strategy:

  • For meals with known carbohydrate content: dose using 1:15 ratio
  • For poor oral intake days: give prandial insulin AFTER eating based on actual consumption 8
  • If meal <30g CHO, consider holding prandial insulin entirely given hypoglycemia risk

Prednisone Consideration

The 5 mg daily prednisone dose is relatively low and given in morning, typically causes afternoon/evening hyperglycemia more than fasting hyperglycemia. Current regimen with morning Lantus is appropriate 4. The recurrent hypoglycemia overrides any hyperglycemic effect from this low steroid dose.

Immediate Action Plan

Days 1-7 (Stabilization Phase):

  1. Lantus: 12 units at 8 am
  2. Hold all correction insulin
  3. Prandial insulin: Use 1:15 ICR, give AFTER meals if >30g CHO consumed
  4. Check BG: Before each meal, bedtime, and 0300
  5. Hypoglycemia protocol: Treat BG <70 mg/dL with 15g fast-acting carbs, recheck in 15 min

Days 8-14 (Reassessment):

  • If no hypoglycemia (BG <70) and fasting BG <180 mg/dL: continue current doses
  • If fasting BG >180 mg/dL consistently: increase Lantus by 2 units 4
  • If hypoglycemia persists: further reduce Lantus to 10 units

After Day 14 (Cautious Titration):

  • May reintroduce correction insulin using ISF 1:80 only if pre-meal BG >250 mg/dL
  • Continue monitoring for hypoglycemia patterns, especially overnight

Critical Pitfalls to Avoid

  1. Do not use "sliding scale" correction insulin alone in this high-risk patient—it caused the current problem 8
  2. Do not give correction insulin with poor oral intake—unpredictable absorption makes hypoglycemia likely
  3. Do not maintain aggressive glycemic targets (A1C <7%) in this setting—accept A1C 7.5-8.5% to prevent severe hypoglycemia 9
  4. Do not forget that insulin clearance continues to decline as CKD progresses—reassess doses every 3 months 3, 10
  5. Prescribe glucagon for emergency hypoglycemia treatment 4, 5

Why These Specific Numbers

The 33% reduction in Lantus (18→12 units) aligns with evidence showing 27-30% lower insulin glargine requirements at eGFR <60 mL/min 2, combined with the guideline recommendation for 10-20% reduction after unexplained hypoglycemia 4. The more conservative ICR (1:15 vs 1:11) provides a 27% reduction in prandial insulin, matching the expected decreased clearance. The ISF of 1:80 is deliberately conservative, prioritizing hypoglycemia prevention over tight glycemic control—appropriate for this high-risk patient 1, 9.

This patient's quality of life and mortality risk are more threatened by recurrent severe hypoglycemia than by modest hyperglycemia—the dose reductions prioritize safety while maintaining reasonable glycemic control 7, 9.

References

8
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

10
Research

Consensus statement on insulin therapy in chronic kidney disease.

Diabetes research and clinical practice, 2017

Related Questions

In a hospitalized patient with chronic kidney disease stage 4 (eGFR ≈ 14 mL/min/1.73 m²) who is taking Xultophy (insulin degludec/liraglutide) 11 units each morning, what long‑acting insulin and what dose should be administered daily during the admission?
Should I increase my basal insulin glargine (Lantus) dose from 10 units given my impaired renal function?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, impaired renal function (creatinine 1.18 mg/dL, eGFR ≈ 77 mL/min) who is on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, and insulin‑sensitivity factor 50 mg/dL per unit, is it appropriate to increase basal Lantus to 15 U, adjust the insulin‑sensitivity factor to 25 mg/dL per unit, and set the insulin‑to‑carbohydrate ratio to 1 U per 8 g carbohydrate?
For a 61‑year‑old man with pancreatogenic diabetes, weighing 53 kg and normal renal function, who is receiving only clear liquids after an insulin drip, should his basal insulin glargine (Lantus) dose be 10 units or 12 units?
In a 176‑kg patient with type 2 diabetes on insulin glargine (Lantus) 30 U daily and insulin aspart (Novolog) 15 U per meal, impaired renal function (creatinine 1.28 mg/dL, eGFR ≈ 68 mL/min), admitted for COPD exacerbation and starting prednisone 60 mg daily, what NPH insulin dose and insulin‑to‑carbohydrate ratio should be used?
What empiric antibiotic should be used while awaiting urine culture results in a patient who has failed azithromycin and macrodantin?
Can intense stress at age 43 cause menopause?
What condition can cause frequent bowel movements, bloating, low ferritin, vitamin B12 deficiency, and vitamin D deficiency?
What is the recommended assessment, treatment, and stepwise return-to-activity protocol for a patient with a concussion?
What is the appropriate management for a patient with dilated pupils due to poisoning?
Is it contraindicated to use a triptan or meclizine in a patient with surgically repaired tetralogy of Fallot?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.